NIMA-Colon Cancer Study
NIMA
Nutritional, Inflammatory, and Muscular Assessment (NIMA) in Patients With Colon Cancer
1 other identifier
interventional
120
1 country
1
Brief Summary
The goal of this study is to evaluate the effects of nutritional supplementation and physical activity interventions on recovery, muscle strength, nutritional status, inflammation, and metabolic health in adults with colon cancer undergoing surgery. Patients with colon cancer frequently experience loss of muscle mass, reduced physical function, and nutritional deterioration both before and after surgery, which may adversely affect recovery and quality of life. A key objective of this study is to assess whether a postoperative intervention combining nutritional supplementation with beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, together with a structured physical activity program, can improve muscle strength and functional recovery following colon cancer surgery. This study aims to answer the following questions:
- Does nutritional supplementation with HMB and vitamin D, combined with postoperative physical activity, improve muscle strength and physical function following colon cancer surgery?
- How do nutritional and lifestyle interventions influence nutritional status, gut microbiota composition, and biological markers of inflammation and metabolism during the recovery period?
- Are there differences in recovery outcomes between patients receiving different types of nutritional support, with or without supervised physical activity? Participants will be adults diagnosed with colon cancer who undergo surgical treatment at the Hospital Universitario Virgen de la Victoria in Málaga, Spain. Patients will be recruited prior to surgery and will enter a prehabilitation phase integrated into routine care provided by the Endocrinology and Nutrition Department. During this prehabilitation phase, nutritional status will be assessed and optimized using standard clinical care, including oral nutritional supplementation when indicated. The aim is to improve the patient's condition before surgery. Approximately one month after surgery, once initial postoperative recovery has been completed, participants will enter the intervention and assessment phase (baseline visit). Participants will then be randomly assigned to one of four study groups in a 2×2 factorial design. These groups combine two nutritional strategies (standard care or supplementation with HMB and vitamin D) and two physical activity approaches (supervised exercise or general activity recommendations). The physical activity component, supervised by the Endocrinology and Nutrition team, will be objectively evaluated using an accelerometer-based device. Participants will be followed for approximately six months, with assessments at about 3 and 6 months after the baseline visit. At each visit, participants will undergo:
- Body composition measurements
- Muscle strength and physical performance tests
- Collection of blood, urine, and stool samples
- Questionnaires on health status and quality of life The results of this study will contribute to a more profound understanding of how tailored nutritional strategies and postoperative physical activity may support recovery and functional health in patients undergoing surgery for colon cancer.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jul 2025
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2025
CompletedFirst Submitted
Initial submission to the registry
February 20, 2026
CompletedFirst Posted
Study publicly available on registry
April 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
August 1, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
December 1, 2027
April 16, 2026
April 1, 2026
2.1 years
February 20, 2026
April 10, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Change in phase angle (PhA)
Phase angle will be assessed by bioelectrical impedance analysis (BIA) as a bioelectrical marker of nutritional and cellular status. Results will be expressed in degrees.
Baseline (first postoperative visit) and 6 months follow-up
Change in quadriceps rectus femoris cross-sectional area
Muscle mass will be assessed using nutritional ultrasound by measuring the cross-sectional area of the quadriceps rectus femoris at a standardized anatomical site (cm²).
Baseline (first postoperative visit) and 6 months follow-up
Secondary Outcomes (5)
Plasma concentration of inflammatory and metabolic biomarkers measured by multiplex immunoassay
From baseline (first postoperative visit), 3 months and 6 months follow-up
Percentage of DNA methylation in peripheral blood mononuclear cells (PBMCs)by quantitative PCR
Baseline (first postoperative visit) and 6 months follow-up
Change in urinary oxylipin concentrations by UHPLC-MS/MS
Baseline (first postoperative visit) and 6 months follow-up
Change in relative abundance of gut microbiota taxa
Baseline (first postoperative visit) and 6 months follow-up
Change in health-related quality of life score (EORTC QLQ-C30)
Baseline (first postoperative visit), 3 months, and 6 months follow-up
Study Arms (4)
Standard nutritional care + supervised exercise program
EXPERIMENTALParticipants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition.
Enhanced nutritional supplementation + non-structured physical activity
EXPERIMENTALParticipants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program.
Enhanced Nutritional Supplementation + Supervised Physical Activity
EXPERIMENTALParticipants receive postoperative enhanced nutritional supplementation, including beta-hydroxy beta-methylbutyrate (HMB) and vitamin D, in addition to standard nutritional care based on routine clinical practice and individualized nutritional assessment. In addition, they participate in a structured supervised exercise program including progressive resistance and functional exercises targeting major muscle groups, adapted to their clinical condition.
Standard nutritional care + general physical activity recommendations
ACTIVE COMPARATORParticipants receive postoperative standard nutritional care according to routine clinical practice and individualized nutritional assessment. Participants also receive general physical activity recommendations according to standard postoperative care without participation in a structured exercise program.
Interventions
Participants receive a standard oral nutritional supplementation consisting of a hypercaloric and hyperproteic formula designed to support recovery and nutritional status in patients undergoing surgery.
Participants receive an oral hypercaloric and hyperproteic nutritional supplementation enriched with β-hydroxy β-methylbutyrate (HMB) and supplemented with vitamin D and calcium. This formulation is designed to support muscle mass preservation and functional recovery in patients undergoing surgical treatment.
Participants follow a structured and supervised physical activity program including resistance exercises and functional training. Physical activity levels are periodically monitored using wearable activity devices.
Participants receive general recommendations for physical activity according to routine clinical practice but do not participate in the structured supervised exercise program.
Eligibility Criteria
You may qualify if:
- Adults aged 18 to 75 years.
- Male and female participants.
- Diagnosis of colon cancer at localized or locally advanced stages (TNM stages I-III).
- Patients scheduled for primary surgical treatment.
You may not qualify if:
- Metastatic disease (stage IV)
- Diagnosis of rectal cancer or tumors involving the rectum
- Prior neoadjuvant chemotherapy or radiotherapy before surgery.
- Presence of synchronous malignant tumors.
- Pregnant or breastfeeding women.
- Presence of severe medical conditions, including acute pancreatitis, severe liver or kidney disease, heart failure, severe pulmonary disease, or peripheral arterial disease affecting the lower limbs.
- Diagnosis of anorexia nervosa or other severe eating disorders.
- Known allergy or intolerance to any nutritional supplements used in the study.
- Medical contraindications to moderate-to-vigorous physical activity.
- Regular participation in high-intensity exercise programs.
- High risk of poor adherence to the study procedures, as determined by the study team.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Hospital Universitario Virgen de la Victoria
Málaga, Malaga, 29010, Spain
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Manuel Macías-Gonzalez, PhD
Fundación Pública Andaluza para la Investigación de Málaga en Biomedicina y Salud (FIMABIS)
- PRINCIPAL INVESTIGATOR
Carolina Muriel-Lopez, PhD
Hospital Regional de Malaga
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Due to the nature of the interventions, participants and care providers are not blinded. Data analysis will be performed using coded group allocation.
- Purpose
- TREATMENT
- Intervention Model
- FACTORIAL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
February 20, 2026
First Posted
April 16, 2026
Study Start
July 1, 2025
Primary Completion (Estimated)
August 1, 2027
Study Completion (Estimated)
December 1, 2027
Last Updated
April 16, 2026
Record last verified: 2026-04